Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Acute myeloid leukemia: Historical perspective and progress in research and therapy over 5 decades
    Review

    Kantarjian, H. M.; Short, N. J.; Fathi, A. T.; Marcucci, G.; Ravandi, F.; Tallman, M.; Wang, E. S.; Wei, A. H.
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Aire regulates chromatin looping by evicting CTCF from domain boundaries and favoring accumulation of cohesin on superenhancers
    Journal Article

    Bansal, K.; Michelson, D. A.; Ramirez, R. N.; Viny, A. D.; Levine, R. L.; Benoist, C.; Mathis, D.
    Proceedings of the National Academy of Sciences of the United States of America (2021)

    Fulltext@MSK | Save
  • Optimizing risk stratification in acute myeloid leukemia: Dynamic models for a dynamic therapeutic landscape
    Editorial

    Short, N. J.; Tallman, M. S.; Pollyea, D. A.; Ravandi, F.; Kantarjian, H.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • All in the family: Back-to-back kinase inhibitors for the treatment of chronic lymphocytic leukemia
    Editorial

    Thompson, M. C.; Roeker, L. E.; Mato, A. R.
    Haematologica (2021)

    Fulltext@MSK | Save
  • IDH inhibitors in acute myeloid leukemia and myelodysplastic syndrome [Interview]
    Miscellaneous

    Stein, E. M.
    Clinical Advances in Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysis
    Journal Article

    de Botton, S.; Brandwein, J. M.; Wei, A. H.; Pigneux, A.; Quesnel, B.; Thomas, X.; Legrand, O.; Recher, C.; Chantepie, S.; Hunault-Berger, M.; more...
    Cancer Medicine (2021)

    Fulltext@MSK | Save
  • Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
    Journal Article

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J. R.; Shouval, R.; Alarcon Tomas, A.; Silverberg, M. L.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Devlin, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Addition of parsaclisib (INCB050465), a PI3Kδ inhibitor, in patients with suboptimal response to ruxolitinib: A phase 2 study in patients with myelofibrosis
    Meeting Abstract

    Yacoub, A.; Wang, E. S.; Rampal, R. K.; Borate, U.; Kremyanskaya, M.; Ali, H.; Hobbs, G. S.; O'Connell, C.; Assad, A.; Erickson-Viitanen, S.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • HMGA1: An epigenetic switch required for MPN progression by inducing GATA-2 and cell cycle progression through enhancer rewiring
    Meeting Abstract

    Li, L.; Kim, J. H.; Lu, W.; Williams, D. M.; Xian, L.; Kim, J.; Rogers, O.; Rampal, R. K.; Koche, R. P.; Cope, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Evolution of OncoKB, a precision oncology knowledgebase
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Zhang, H.; Smith, S.; Nissan, M.; Yao, Y.; LaFave, L.; Gala, K.; Miles, L.; Arcila, M. E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save